📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! Tell us what works, what doesn't, and how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community. Please send your feedback to gateway@ukri.org by 11 August 2025.

Fetal gene therapy could be feasible for neuronopathic Gaucher disease. (2018)

First Author: Wood H

Attributed to: Gene therapy for Childhood Parkinsonism: Dopamine transporter deficiency syndrome funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41582-018-0053-4

PubMed Identifier: 30061714

Publication URI: http://europepmc.org/abstract/MED/30061714

Type: Journal Article/Review

Volume: 14

Parent Publication: Nature reviews. Neurology

Issue: 9

ISSN: 1759-4758